Le Lézard
Classified in: Health
Subjects: SVY, HSP, BFA, ASI, BLK, NTA, DEI

Breastcancer.org Urges People to Get Informed About Clinical Trials


PHILADELPHIA, Oct. 12, 2021 /PRNewswire/ -- Breastcancer.org, a leading source of patient-focused breast cancer information and an online community for people impacted by breast cancer, released a new Special Report today on increasing racial diversity in breast cancer clinical trials. Several experts leading efforts to improve access to clinical trials will be speaking at the organization's virtual town hall on Wednesday, October 13, at 7 p.m. ET and answering audience questions about clinical trials. The event is free and open to the public, and everyone who registers will receive a recording of the program.

In the United States, racial and ethnic minorities have been underrepresented in cancer clinical trials for decades, even when they have a similar or higher risk of the type of cancer being studied. Not being included in clinical trials may be one of the reasons that Black women have worse breast cancer outcomes than other racial and ethnic groups. Black women and white women in the United States get breast cancer at about the same rate, but Black women are 40% more likely to die of breast cancer.

"We need everyone appropriately represented because we want to make sure a therapy works the same way and the side effects are the same in different populations," said Karen Winkfield, M.D., Ph.D., executive director of the Meharry-Vanderbilt Alliance in Nashville, Tennessee, and a contributor to the Special Report.   

The Breastcancer.org report examines common barriers that prevent people from enrolling or remaining in a clinical trial, including:

Read the full list and learn how people affected by breast cancer can find clinical trials on Breastcancer.org.

The Special Report was developed with medical experts and through interviews with Black women who participated in breast cancer clinical trials. The resounding message is that awareness, education, and self-advocacy can improve clinical trial inclusion. Systemic change will be a result of doctors, researchers, pharmaceutical companies, medical societies, government health agencies, and research institutions doing their part to increase access to clinical trials for people of color.

The virtual event to discuss the report, Diversity In Clinical Trials: Your Participation Matters, begins at 7 p.m. ET on Wednesday, October 13. Featured speakers include Marisa Weiss, M.D., Breastcancer.org chief medical officer; Nadine J. Barrett, Ph.D., MS, MA, director, Center for Equity in Research, Duke Clinical Translational Science Institute, Duke University; Karen Winkfield, M.D., Ph.D., executive director of the Meharry-Vanderbilt Alliance in Nashville, Tennessee; Lola Fayanju, M.D., MA, MPHS, FACS, chief of breast surgery at Penn Medicine; and Athena Jones, CNN National Correspondent. Registration will remain open until the start of the program.

About Breastcancer.org

Breastcancer.org is a leading patient-focused resource for breast health and breast cancer education and support. Their mission is to engage and empower people with research, expert information, and a dynamic peer support community to help them make the best decisions for their lives. The nonprofit organization, founded in 2000 by chief medical officer Marisa C. Weiss, M.D., has reached 174 million people worldwide since inception. Visit www.Breastcancer.org for more information.

 

SOURCE Breastcancer.org


These press releases may also interest you

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 07:00
Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on TERLIVAZ® (terlipressin) for injection in patients with hepatorenal syndrome (HRS) with rapid reduction in kidney function1 at the 2024...

17 mai 2024
Family Braces, Calgary's largest group of orthodontists with five locations across the city, reports a strong start to the second quarter of 2024. This positive momentum builds on the group's successful first quarter, underlining its...

17 mai 2024
American Skin Association (ASA) announced the recipients of the 2024 Inaugural Founders Award and the 2024 Research Achievement Awards at the 2024 Society for Investigative Dermatology (SID) Annual Meeting. ...



News published on and distributed by: